Establishment of an In Vitro Disease Model of Charcot-Marie-Tooth Disease using Human Induced Pluripotent Stem Cells

XING LIU; KEI-ICHI ISHIKAWA; NOBUTAKA HATTORI; WADO AKAMATSU

doi:10.14789/ejmj.JMJ24-0046-R

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Establishment of an In Vitro Disease Model of Charcot-Marie-Tooth Disease using Human Induced Pluripotent Stem Cells

XING LIU, KEI-ICHI ISHIKAWA , NOBUTAKA HATTORI, WADO AKAMATSU

著者情報

キーワード: iPSC, Charcot-Marie-Tooth disease, PMP22, Schwann cell, peripheral neuropathy

ジャーナルオープンアクセス早期公開

論文ID: JMJ24-0046-R

DOI https://doi.org/10.14789/ejmj.JMJ24-0046-R

この記事には本公開記事があります。

The final version of this article is now available: Vol. 71 (2025), No. 3 pp. 156-157

詳細

抄録

　Charcot-Marie-Tooth disease type 1A (CMT1A) is a hereditary neuropathy caused by the duplication of the PMP22 gene, leading to Schwann cell dysfunction and peripheral demyelination. We developed a Schwann cell lineage model derived from induced pluripotent stem cells (iPSCs) obtained from a CMT1A patient. This model exhibited disease-specific phenotypes, providing a valuable platform for investigating the pathophysiology of CMT1A and exploring therapeutic strategies.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）